The endocannabinoid system: An overview

Natalia Battista, Monia Di Tommaso, Monica Bari, Mauro Maccarrone

Research output: Contribution to journalArticle

Abstract

Upon the identification of anandamide (AEA) in the porcine brain, numerous studies contributed to the current state of knowledge regarding all elements that form the "endocannabinoid system (ECS)". How this complex system of receptors, ligands and enzymes is integrated in helping to regulate fundamental processes at level of central nervous and peripheral systems and how its regulation and dysregulation might counteract disturbances of such functions, is nowadays still under investigation. However, the most recent advances on the physiological distribution and functional role of ECS allowed the progress of various research tools aimed at the therapeutic exploitation of endocannabinoid (eCB) signaling, as well as the development of novel drugs with pharmacological advantages. Here, we shall briefly overview the metabolic and signal transduction pathways of the main eCBs representatives, AEA and 2-arachidonoylglycerol (2-AG), and we will discuss the therapeutic potential of new ECS-oriented drugs.

Original languageEnglish
JournalFrontiers in Behavioral Neuroscience
Issue numberFEBRUARY 2012
DOIs
Publication statusPublished - Feb 27 2012

Fingerprint

Endocannabinoids
Pharmaceutical Preparations
Signal Transduction
Swine
Central Nervous System
Pharmacology
Ligands
Brain
Enzymes
Therapeutics
Research

Keywords

  • 2-arachidonoylglycerol
  • Anandamide
  • Endocannabinoids
  • Metabolic pathways
  • Signal transduction

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Cognitive Neuroscience
  • Neuropsychology and Physiological Psychology

Cite this

The endocannabinoid system : An overview. / Battista, Natalia; Tommaso, Monia Di; Bari, Monica; Maccarrone, Mauro.

In: Frontiers in Behavioral Neuroscience, No. FEBRUARY 2012, 27.02.2012.

Research output: Contribution to journalArticle

Battista, Natalia ; Tommaso, Monia Di ; Bari, Monica ; Maccarrone, Mauro. / The endocannabinoid system : An overview. In: Frontiers in Behavioral Neuroscience. 2012 ; No. FEBRUARY 2012.
@article{cf115090ea1a4294a542f5bc8018c90b,
title = "The endocannabinoid system: An overview",
abstract = "Upon the identification of anandamide (AEA) in the porcine brain, numerous studies contributed to the current state of knowledge regarding all elements that form the {"}endocannabinoid system (ECS){"}. How this complex system of receptors, ligands and enzymes is integrated in helping to regulate fundamental processes at level of central nervous and peripheral systems and how its regulation and dysregulation might counteract disturbances of such functions, is nowadays still under investigation. However, the most recent advances on the physiological distribution and functional role of ECS allowed the progress of various research tools aimed at the therapeutic exploitation of endocannabinoid (eCB) signaling, as well as the development of novel drugs with pharmacological advantages. Here, we shall briefly overview the metabolic and signal transduction pathways of the main eCBs representatives, AEA and 2-arachidonoylglycerol (2-AG), and we will discuss the therapeutic potential of new ECS-oriented drugs.",
keywords = "2-arachidonoylglycerol, Anandamide, Endocannabinoids, Metabolic pathways, Signal transduction",
author = "Natalia Battista and Tommaso, {Monia Di} and Monica Bari and Mauro Maccarrone",
year = "2012",
month = "2",
day = "27",
doi = "10.3389/fnbeh.2012.00009",
language = "English",
journal = "Frontiers in Behavioral Neuroscience",
issn = "1662-5153",
publisher = "Frontiers Research Foundation",
number = "FEBRUARY 2012",

}

TY - JOUR

T1 - The endocannabinoid system

T2 - An overview

AU - Battista, Natalia

AU - Tommaso, Monia Di

AU - Bari, Monica

AU - Maccarrone, Mauro

PY - 2012/2/27

Y1 - 2012/2/27

N2 - Upon the identification of anandamide (AEA) in the porcine brain, numerous studies contributed to the current state of knowledge regarding all elements that form the "endocannabinoid system (ECS)". How this complex system of receptors, ligands and enzymes is integrated in helping to regulate fundamental processes at level of central nervous and peripheral systems and how its regulation and dysregulation might counteract disturbances of such functions, is nowadays still under investigation. However, the most recent advances on the physiological distribution and functional role of ECS allowed the progress of various research tools aimed at the therapeutic exploitation of endocannabinoid (eCB) signaling, as well as the development of novel drugs with pharmacological advantages. Here, we shall briefly overview the metabolic and signal transduction pathways of the main eCBs representatives, AEA and 2-arachidonoylglycerol (2-AG), and we will discuss the therapeutic potential of new ECS-oriented drugs.

AB - Upon the identification of anandamide (AEA) in the porcine brain, numerous studies contributed to the current state of knowledge regarding all elements that form the "endocannabinoid system (ECS)". How this complex system of receptors, ligands and enzymes is integrated in helping to regulate fundamental processes at level of central nervous and peripheral systems and how its regulation and dysregulation might counteract disturbances of such functions, is nowadays still under investigation. However, the most recent advances on the physiological distribution and functional role of ECS allowed the progress of various research tools aimed at the therapeutic exploitation of endocannabinoid (eCB) signaling, as well as the development of novel drugs with pharmacological advantages. Here, we shall briefly overview the metabolic and signal transduction pathways of the main eCBs representatives, AEA and 2-arachidonoylglycerol (2-AG), and we will discuss the therapeutic potential of new ECS-oriented drugs.

KW - 2-arachidonoylglycerol

KW - Anandamide

KW - Endocannabinoids

KW - Metabolic pathways

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=84857852475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857852475&partnerID=8YFLogxK

U2 - 10.3389/fnbeh.2012.00009

DO - 10.3389/fnbeh.2012.00009

M3 - Article

C2 - 22457644

AN - SCOPUS:84857852475

JO - Frontiers in Behavioral Neuroscience

JF - Frontiers in Behavioral Neuroscience

SN - 1662-5153

IS - FEBRUARY 2012

ER -